Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 1336 AL 1350

Case study on the treatment of dopamine dysregulation syndrome

Du J, Wei L.

Technol Health Care. 2023;31(4):1493-1496. doi: 10.3233/THC-220719.

Electroanalytical Overview: The Determination of Levodopa (L-DOPA)

Crapnell RD, Banks CE.

ACS Meas Sci Au. 2023 Feb 3;3(2):84-97. doi: 10.1021/acsmeasuresciau.2c00071. eCollection 2023 Apr 19.

30 years of American Society for Neural Therapy and Repair (ASNTR): A personal perspective at the intersection of science, politics, and culture

Sanberg PR, Morrison DC, Bjugstad KB.

Neurosci Biobehav Rev. 2023 Aug;151:105234. doi: 10.1016/j.neubiorev.2023.105234. Epub 2023 May 16.

Molecular Regulation of the CNS by Vitamin D

Máčová L, Kancheva R, Bičíková M.

Physiol Res. 2023 Dec 17;72(S4):S339-S356. doi: 10.33549/physiolres.935248.

Potassium Channels in Parkinson's Disease: Potential Roles in Its Pathogenesis and Innovative Molecular Targets for Treatment

Chen X, Feng Y, Quinn RJ, Pountney DL, Richardson DR, Mellick GD, Ma L.

Pharmacol Rev. 2023 Jul;75(4):758-788. doi: 10.1124/pharmrev.122.000743. Epub 2023 Mar 14.

NF-κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective

Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Papadakis M, Jabir MS, Saad HM, Batiha GE.

J Cell Mol Med. 2023 Jul;27(13):1775-1789. doi: 10.1111/jcmm.17784. Epub 2023 May 21.

Evidence-Based Taiwan Consensus Recommendations for the treatment of Parkinson's disease

Treatment Guideline Subcommittee of Taiwan Movement Disorder Society.

Acta Neurol Taiwan. 2023 Sep 30;32(3):145-184.

Background and roles: myosin in autoimmune diseases

Fu L, Zou Y, Yu B, Hong D, Guan T, Hu J, Xu Y, Wu Y, Kou J, Lv Y.

Front Cell Dev Biol. 2023 Aug 23;11:1220672. doi: 10.3389/fcell.2023.1220672. eCollection 2023.

Development of fluorophores for the detection of oligomeric aggregates of amyloidogenic proteins found in neurodegenerative diseases

Teppang KL, Zhao Q, Yang J.

Front Chem. 2023 Dec 22;11:1343118. doi: 10.3389/fchem.2023.1343118. eCollection 2023.

Dopamine control of downstream motor centers

Ryczko D, Dubuc R.

Curr Opin Neurobiol. 2023 Dec;83:102785. doi: 10.1016/j.conb.2023.102785. Epub 2023 Sep 27.

Case Report: Cedecea lapagei Infection: Report of a Case in Peru and Review of the Literature

Al-Kassab-Córdova A, Valdiviezo-Polo P, Ulloque-Badaracco JR, Honorio-Arroyo CL, Hueda-Zavaleta M, Benites-Zapata VA.

Am J Trop Med Hyg. 2023 Jun 20;109(2):356-367. doi: 10.4269/ajtmh.23-0168. Print 2023 Aug 2.

Reconceptualizing Catatonia as "Psychiatric Parkinsonism"

Hinkle JT, Pontone GM.

Am J Geriatr Psychiatry. 2023 Dec;31(12):1206-1208. doi: 10.1016/j.jagp.2023.07.010. Epub 2023 Jul 23.

Anti-amyloid potential of some phytochemicals against Aβ-peptide and α-synuclein, tau, prion, and Huntingtin protein

Jerom JP, Madhukumar S, Nair RH, Narayanan SP.

Drug Discov Today. 2023 Dec;28(12):103802. doi: 10.1016/j.drudis.2023.103802. Epub 2023 Oct 17.

Quantitative MRI protocol and decision model for a 'one stop shop' early-stage Parkinsonism diagnosis: Study design

Seada SA, van der Eerden AW, Boon AJW, Hernandez-Tamames JA.

Neuroimage Clin. 2023;39:103506. doi: 10.1016/j.nicl.2023.103506. Epub 2023 Sep 9.

An update on the role of Hippo signaling pathway in ischemia-associated central nervous system diseases

Wei X, Huang G, Liu J, Ge J, Zhang W, Mei Z.

Biomed Pharmacother. 2023 Jun;162:114619. doi: 10.1016/j.biopha.2023.114619. Epub 2023 Mar 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias